Smyth LM, Tamura K, Oliveira M, Ciruelos EM, et al. Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination With Fulvestrant in Patients With AKT1 (E17K)-Mutant, ER-Positive Metastatic Breast Cancer. Clin Cancer Res 2020 Apr 20. pii: 1078-0432.CCR-19-3953.
PMID: 32312891